ALTEPLASE — all Canadian products
5 DINs
3 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is ALTEPLASE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02147440 | ACTIVASE RT-PA | HOFFMANN-LA ROCHE LIMITED | Powder For Solution; Liquid | Intravenous | ALTEPLASE 100 MG; WATER 100 ML | Marketed | |
| 02225689 | ACTIVASE RT-PA | HOFFMANN-LA ROCHE LIMITED | Liquid; Powder For Solution | Intravenous | ALTEPLASE 50 MG; WATER 50 ML | Marketed | |
| 02245859 | CATHFLO | HOFFMANN-LA ROCHE LIMITED | Powder For Solution | Instillation | ALTEPLASE 2 MG | Marketed | |
| 00771473 | ACTIVASE RT-PA INJ | HOFFMANN-LA ROCHE LIMITED | Powder For Solution | Intravenous | ALTEPLASE 29 M | Cancelled Post Market | |
| 02009285 | LYSATEC RT - PA | GENENTECH INC | Powder For Solution | Intravenous | ALTEPLASE 50 MG; WATER 50 ML | Cancelled Post Market |
Browse other molecules: